USC News

Menu Search

Sen. Kevin de León talks biotech with USC leaders

Research in regenerative medicine can be a game-changer in the treatment of damaged organs, the senator says

Kevin De León says bioscience will continue to be a statewide priority
Sen. Kevin de León listens to Provost Professor Andrew McMahon as Martha Escutia looks on during a visit to a USC lab. (USC Photo/David Sprague)

State Senate President Pro Tem Kevin de León (D-Los Angeles) met with Martha Escutia, vice president of government relations, and Provost Professor Andrew McMahon to discuss plans to build a biotechnology park on the university’s Health Sciences Campus. The meeting took place at the Eli and Edythe Broad Center for Regenerative Medicine and Stem Cell Research at USC on Sept. 18.

The plan, which has gained support from key city and county partners, is expected to create as many as 3,000 new construction jobs and almost 4,000 permanent jobs — most of which will be open to members of the local community as well as to medical and research professionals.

“Research in the field of regenerative medicine has the potential to be a game-changer in the treatment of damaged tissue and organs — the difference between managing symptoms versus full recovery,” Sen. de León said. “The work being done here at USC ensures that California will maintain its integral role in the field of biotechnology and the resulting advances that benefit us all.”

Escutia added: “Biotechnology and bioscience-related industries are tackling pressing global health issues such as Alzheimer’s disease and cancer. This is an opportunity for bioscience research, its funding and its workforce to remain in Los Angeles.”

More stories about: , ,

Sen. Kevin de León talks biotech with USC leaders

Top stories on USC News